| epirubicin / Generic mfg. |
| Completed | 3 | 226 | Europe | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Epirubicin, Vinblastine, Rituximab, G-CSF | Fondazione Italiana Linfomi ONLUS | Elderly Patients (>65 Years), Diffuse Large B Cell Lymphoma (DLBCL) | 01/06 | | | |
NCT00854568: Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL |
|
|
| Completed | 3 | 398 | RoW | CEOP regimen, CEOP, CHOP regimen, CHOP | Fudan University | Lymphoma | 12/12 | 02/13 | | |
NCT03151044: R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL |
|
|
| Unknown status | 3 | 408 | RoW | High-dose Epirubicin Combined with CVP ± Rituximab, R±CEOP90, Standard-dose Epirubicin Combined with CVP ± Rituximab, R±CEOP75 | FENG Ji-feng, Chinese Anti-Cancer Association | Diffuse Large B-cell Lymphoma | 07/17 | 07/17 | | |
NCT02767674: Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma |
|
|
| Unknown status | 3 | 258 | RoW | Rituximab, Gemcitabine, Oxaliplatin, Cyclophosphamide, Epirubicin Injectable Product, Vindesine, Prednisone | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B Cell Lymphoma | 12/20 | 12/20 | | |
NCT05164770: Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 3 | 160 | RoW | Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX, R-CHOP; R-DA-EPOCH; R-HD MTX | Shandong Provincial Hospital | High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B Cell Lymphoma, B-cell Non Hodgkin Lymphoma, Mantle Cell Lymphoma | 12/23 | 12/24 | | |
NCT05097443: Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 3 | 130 | RoW | Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies | Shandong Provincial Hospital | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, B-cell NonHodgkin Lymphoma | 12/23 | 12/24 | | |
NCT02871869: Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma |
|
|
| Unknown status | 2/3 | 316 | RoW | vindesine, eldisine, cyclophosphamide, endoxan, Epirubicin, EPI, prednisone tablets, metacortandracin, Cinobufacini Tablets, buformin, Rituximab, RTX | Xinjiang Medical University | Diffuse, Large B-Cell, Lymphoma | 09/18 | 12/21 | | |
